Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs

Doxil® — The first FDA-approved nano-drug: Lessons learned

(2012) Yechezkel (Chezy) Barenholz   JOURNAL OF CONTROLLED RELEASE

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

(2012) Julian R. Molina et al.   MAYO CLINIC PROCEEDINGS

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

(2012) J. Hrkach et al.   Science Translational Medicine

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours

(2011) R Plummer et al.   BRITISH JOURNAL OF CANCER

A Phase II Study of Lipoplatin (Liposomal Cisplatin)/Vinorelbine Combination in HER-2/neu–Negative Metastatic Breast Cancer

(2011) Fadi S. Farhat et al.   Clinical Breast Cancer

2011 AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics

(2011) Neil Bennet   LANCET ONCOLOGY

Bio-inspired, bioengineered and biomimetic drug delivery carriers

(2011) Jin-Wook Yoo et al.   NATURE REVIEWS DRUG DISCOVERY

Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial

(2010) G. P. Stathopoulos et al.   ANNALS OF ONCOLOGY

The status of platinum anticancer drugs in the clinic and in clinical trials

(2010) Nial J. Wheate et al.   DALTON TRANSACTIONS

Concurrent Liposomal Cisplatin (Lipoplatin), 5-Fluorouracil and Radiotherapy for the Treatment of Locally Advanced Gastric Cancer: A Phase I/II Study

(2010) Michael I. Koukourakis et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Cancer Therapies Utilizing the Camptothecins: A Review of thein VivoLiterature

(2010) Vincent J. Venditto et al.   MOLECULAR PHARMACEUTICS

Biocompatibility and drug delivery systems

(2010) Daniel S. Kohane et al.   Chemical Science

Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture

(2009) Megan E. Fox et al.   ACCOUNTS OF CHEMICAL RESEARCH

XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer

(2009) Alexander V. Yurkovetskiy et al.   ADVANCED DRUG DELIVERY REVIEWS

ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic

(2009) David P Nowotnik et al.   ADVANCED DRUG DELIVERY REVIEWS

Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines

(2009) Francesca Greco et al.   ADVANCED DRUG DELIVERY REVIEWS

Prodrug Approaches for Enhancing the Bioavailability of Drugs with Low Solubility

(2009) Christa E. Müller   CHEMISTRY & BIODIVERSITY

Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer

(2009) N. Mylonakis et al.   LUNG CANCER

Polymeric Micellar Delivery Systems in Oncology

(2008) Y. Matsumura   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Prodrug Strategies in Anticancer Chemotherapy

(2007) Felix Kratz et al.   ChemMedChem

Towards the rational design of platinum(ii) and gold(iii) complexes as antitumour agents

(2007) Xiaoyong Wang et al.   DALTON TRANSACTIONS